Adabale Abosede, Makanjuola Samira Batista Lobo, Akinbami Akinsegun, Dosunmu Adedoyin, Akanmu Alani, Javid Farideh A, Ajonuma Louis C
Department of Haematology and Blood Transfusion, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Department of Pharmacology, Toxicology and Therapeutics, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
J Int Med Res. 2021 Jun;49(6):3000605211019918. doi: 10.1177/03000605211019918.
To determine the frequency of beta s globin gene haplotypes in Nigerian patients with sickle cell disease (SCD) and to measure their correlation with clinical and haematological characteristics.
This study enrolled patients with SCD and collected their peripheral blood for restriction fragment length polymorphism analysis in order to identify five polymorphic sites in the β-globin gene cluster.
A total of 245 homozygous SCD patients (490 alleles) were included in the study. Among the analysed alleles, 426 (86.9%) had the Benin (BEN) haplotype; 19 (3.9%) had the Senegal (SEN) haplotype; 31 (6.3%) had the Cameroon haplotype; five (1.0%) had the Bantu/Central African Republic haplotype; and nine 9 (1.8%) had atypical haplotypes. No significant association was observed between the haplotypes and haematological events, although patients with the BEN/SEN haplotype showed improved red blood cell counts, haemoglobin levels and red blood cell width index. No significant association was observed between the haplotypes and the three clinical manifestations, although patients with the BEN/SEN haplotype showed a four-fold lower frequency of painful episodes.
These findings suggest that the SEN haplotype combined with the BEN haplotype might contribute toward a better haematological profile and milder clinical severity in SCD.
确定尼日利亚镰状细胞病(SCD)患者中β珠蛋白基因单倍型的频率,并测量其与临床和血液学特征的相关性。
本研究纳入了SCD患者,并采集他们的外周血进行限制性片段长度多态性分析,以识别β珠蛋白基因簇中的五个多态性位点。
本研究共纳入245例纯合SCD患者(490个等位基因)。在分析的等位基因中,426个(86.9%)具有贝宁(BEN)单倍型;19个(3.9%)具有塞内加尔(SEN)单倍型;31个(6.3%)具有喀麦隆单倍型;5个(1.0%)具有班图/中非共和国单倍型;9个(1.8%)具有非典型单倍型。单倍型与血液学事件之间未观察到显著关联,尽管具有BEN/SEN单倍型的患者红细胞计数、血红蛋白水平和红细胞宽度指数有所改善。单倍型与三种临床表现之间未观察到显著关联,尽管具有BEN/SEN单倍型的患者疼痛发作频率降低了四倍。
这些发现表明,SEN单倍型与BEN单倍型相结合可能有助于改善SCD患者的血液学特征并减轻临床严重程度。